Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions - Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

被引:349
作者
Horie, K
Miyata, T [1 ]
Maeda, K
Miyata, S
Sugiyama, S
Sakai, H
de Strihou, CV
Monnier, VM
Witztum, JL
Kurokawa, K
机构
[1] Tokai Univ, Sch Med, Inst Med Sci, Isehara, Kanagawa 25911, Japan
[2] Tokai Univ, Sch Med, Dept Med, Isehara, Kanagawa 25911, Japan
[3] Nagoya Univ, Sch Med, Dept Internal Med, Nagoya, Aichi 461, Japan
[4] Kobe Univ, Sch Med, Dept Internal Med, Kobe, Hyogo 650, Japan
[5] Chukyo Hosp, Nagoya, Aichi 457, Japan
[6] Univ Catholique Louvain, Serv Nephrol, B-1200 Brussels, Belgium
[7] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
[8] Univ Calif San Diego, Dept Endocrinol & Metab, San Diego, CA 92093 USA
关键词
advanced glycation end products; pentosidine; carboxymethyllysine; malondialdehyde; local oxidative stress;
D O I
10.1172/JCI119853
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Advanced glycation end products (AGEs) include a variety of protein adducts whose accumulation alters the structure and function of tissue proteins and stimulates cellular responses, They have been implicated in tissue damage associated with diabetic complications, To assess the possible link between AGE accumulation and the development of diabetic nephropathy (DN), we have examined the immunohistochemical localization of various AGE structures postulated to date, i.e., pentosidine, N-epsilon-(carboxymethyl)lysine (CML), and pyrraline, in diabetic and control kidneys. CML and pentosidine accumulate in the expanded mesangial matrix and thickened glomerular capillary walls of early DN and in nodular lesions and arterial walls of advanced DN, but were absent in control kidneys, By contrast, pyrraline was not found within diabetic glomeruli but was detected in the interstitial connective tissue of both normal and diabetic kidneys, Although the distribution of pyrraline was topographically identical to type III collagen, distribution of pentosidine and CML was not specific for collagen type, suggesting that difference in matrix protein composition per se could not explain heterogeneous AGE localization. Since oxidation is linked closely to the formation of pentosidine and CML, we also immunostained malondialdehyde (MDA), a lipid peroxidation product whose formation is accelerated by oxidative stress, assuming that local oxidative stress may serve as a mechanism of pentosidine and CML accumulation, Consistent with our assumption, diabetic nodular lesions were stained positive for MDA. These findings show that AGE localization in DN varies according to AGE structure, and suggest that the colocalization of markers of glycoxidation (pentosidine and CML) with a marker of lipid peroxidation reflects a local oxidative stress in association with the pathogenesis of diabetic glomerular lesions, Thus, glycoxidation markers may serve as useful biomarkers of oxidative damage in DN.
引用
收藏
页码:2995 / 3004
页数:10
相关论文
共 55 条
[1]  
AHMED MU, 1986, J BIOL CHEM, V261, P4889
[2]   Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein - A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation [J].
Anderson, MM ;
Hazen, SL ;
Hsu, FF ;
Heinecke, JW .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03) :424-432
[3]   IMPROVEMENT OF BLOOD-GLUCOSE CONTROL IN IDDM PATIENTS RETARDS THE PROGRESSION OF MORPHOLOGICAL-CHANGES IN EARLY DIABETIC NEPHROPATHY [J].
BANGSTAD, HJ ;
OSTERBY, R ;
DAHLJORGENSEN, K ;
BERG, KJ ;
HARTMANN, A ;
HANSSEN, KF .
DIABETOLOGIA, 1994, 37 (05) :483-490
[4]   ROLE OF OXIDATIVE STRESS IN DEVELOPMENT OF COMPLICATIONS IN DIABETES [J].
BAYNES, JW .
DIABETES, 1991, 40 (04) :405-412
[5]  
Baynes JW, 1989, PROG CLIN BIOL RES, V304, P1
[6]   INCREASED COLLAGEN-LINKED PENTOSIDINE LEVELS AND ADVANCED GLYCOSYLATION END-PRODUCTS IN EARLY DIABETIC NEPHROPATHY [J].
BEISSWENGER, PJ ;
MOORE, LL ;
BRINCKJOHNSEN, T ;
CURPHEY, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :212-217
[7]  
BRETT J, 1993, AM J PATHOL, V143, P1699
[8]  
BROWNLEE M, 1988, NEW ENGL J MED, V318, P1315
[9]  
Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703
[10]   THE ROLE OF REACTIVE OXYGEN SPECIES IN ANIMAL-MODELS OF GLOMERULAR-DISEASE [J].
DIAMOND, JR .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 19 (03) :292-300